NASDAQ:CAPR - Capricor Therapeutics, Inc.
$5.42
 $-0.22
-3.90%
12:50PM EDT
2019-07-22
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapeutics. The Company focuses on discovering, developing and commercializing regenerative medicine and large molecule products for the treatment of disease, with a primary focus on the treatment of cardiovascular diseases, including orphan indications. Its product candidate, CAP-1002, a cardiosphere-derived cell product, is being tested in the ALLSTAR Phase II clinical study on patients having suffered a myocardial infarction (MI), while the DYNAMIC clinical study is testing CAP-1002 in patients in the advanced-stage of heart failure. CAP-1002 is also being tested in the HOPE-Duchenne Phase I/II clinical study for use in connection with Duchenne muscular dystrophy-related cardiomyopathy. Cenderitide, a dual receptor natriuretic peptide agonist, is being tested in a Phase II clinical study. Exosomes are nano-sized, membrane-enclosed vesicles. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CAPR     avg for
industry  
  avg for
sector  
42 stocks weight:  1. 58   217. 37   399. 45  
42 stocks rank:  4. 46 K 1. 27 K 716. 99  
# analyst opinions:  1. 00   13. 21   13. 71  
mean recommendation:  2. 50   2. 10   2. 04  

quick ratio:  4. 86   5. 49   1. 88  
current ratio:  5. 27   5. 87   2. 36  

target price low:  12. 40   83. 44   114. 90  
target price avg:  12. 40   106. 20   137. 90  
target price high:  12. 40   132. 30   158. 97  
1-yr high:  12. 70   111. 86   142. 57  
last close:  5. 64   86. 79   125. 44  
50-day avg:  3. 63   86. 68   122. 63  
200-day avg:  5. 64   89. 22   121. 38  
1-yr low:  2. 75   69. 78   100. 51  
volume:  506. 40 K 2. 62 M 3. 43 M
50-day avg volume:  928. 84 K 3. 20 M 4. 16 M
200-day avg volume:  249. 94 K 2. 99 M 4. 75 M

1-day return:  7. 43 % -1. 30 % -0. 99 %
this week return:  75. 16 % 0. 45 % -0. 20 %
12-wk return:  12. 80 % 0. 94 % 4. 84 %
52-wk return:  -58. 66 % -1. 30 % 10. 55 %

enterprise value (EV):  12. 39 M 45. 10 B 122. 38 B
market cap:  19. 56 M 38. 96 B 108. 40 B
EBITDA:  -14. 03 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -0. 88   5. 38   11. 93  
enterprise/revenue (EV/R):  8. 25   57. 92   10. 21  
total revenue:  1. 50 M 9. 91 B 39. 98 B
total debt:  0. 00   10. 90 B 17. 48 B
net income (common):  -14. 04 M 2. 07 B 4. 05 B

shares outstanding:  34. 68 M 538. 09 M 1. 24 B
shares:  2. 36 M 548. 00 M 1. 22 B
shares short:  34. 31 K 10. 98 M 11. 87 M
shares short prior month:  32. 80 K 9. 32 M 12. 05 M
short ratio:  0. 52   5. 60   3. 34  
short % of float:  1. 28 % 6. 48 % 2. 64 %
total cash/share:  2. 07   10. 98   9. 19  
total cash:  7. 17 M 5. 93 B 6. 10 B
free cash flow:  -6. 61 M 2. 92 B 4. 55 B
operating cash flow:  -12. 05 M 3. 80 B 5. 78 B

book value:  1. 11   13. 35   27. 45  
price/book:  5. 08   4. 60   8. 78  
gross profits:  -10. 40 M 7. 44 B 36. 13 B
operating margins:  -945. 41 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -4. 58   2. 10   4. 23  
forward EPS:  -2. 70   3. 45   7. 10  
P/E:  -1. 23   1. 90   32. 10  
forward P/E:  -2. 09   6. 46   15. 47  
PE/G:  0. 03   0. 70   -0. 54  
growth:  -42. 40 % 265. 63 % 79. 11 %
earnings high:  -0. 00   0. 89   1. 68  
earnings avg:  -0. 00   0. 70   1. 57  
earnings low:  -0. 00   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  231. 00 K 2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -73. 93 % -2. 34 % 5. 28 %
return on equity:  -196. 70 % -90. 08 % 133. 53 %
revenue growth:  -42. 40 % 265. 25 % 73. 68 %
revenue/share:  0. 49   12. 72   60. 04  

beta (1yr vs S&P500):  0. 92   1. 27   0. 91  
sharpe (1yr):  -0. 07   0. 16   0. 77  

held % insiders:  32. 93 % 6. 06 % 3. 29 %
held % institutions:  4. 93 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : CAPR
.    104.246 =       104.246 :: --> INITIAL WEIGHT <--
.    - 4.575 =        99.671 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.984 =       197.767 :: P/E factor
.    x 2.209 =        436.86 :: PE/G factor
.     x 1.51 =       659.508 :: beta factor
.    x 0.662 =       436.383 :: sharpe factor
.    x 2.897 =      1264.383 :: current ratio factor
.    x 1.122 =      1418.779 :: quick ratio factor
.    x 1.773 =      2515.985 :: short ratio factor
.    x 1.142 =      2874.244 :: EV/R factor
.    x 1.063 =      3054.312 :: price-to-book factor
.                               --> PERFORMANCE <--
.    x 2.121 =      6477.565 :: sector+industry 1-year gains factor
.    x 1.009 =      6538.636 :: industry 12-weeks return factor
.    x 1.308 =      8551.807 :: industry 2-weeks return factor
.    x 1.044 =      8924.511 :: 5-day avg > 200-day avg
.    x 3.472 =     30987.794 :: 5-day avg > 50-day avg
.    x 0.687 =      21285.57 :: "drift" penalty 1 days ago
.    x 0.945 =     20109.091 :: "drift" penalty 4 days ago
.    / 2.319 =      8672.457 :: overall "drift" factor
.      x 0.0 =         3.642 :: largest single-day jump factor
.    x 0.087 =         0.316 :: low price factor
.    x 0.003 =         0.001 :: notable returns + performance factor
.    x 0.003 =           0.0 :: performance vs s&p500 factor
.                               --> PROJECTIONS <--
.    x 0.729 =           0.0 :: forward EPS factor
.    x 0.902 =           0.0 :: forward P/E factor
.    x 1.185 =           0.0 :: industry recommendation factor
.     x 1.87 =           0.0 :: company recommendation factor
.    x 1.003 =           0.0 :: factor historical industry gain for week 29
.   x 10.899 =           0.0 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.    + 1.581 =         1.581 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      1.581 :: FINAL WEIGHT for NASDAQ:CAPR


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org